作者:
Placke,T. [1]
;
Faber,K. [2]
;
Nonami,A. [3]
;
Putwain,S.L. [4]
;
Salih,H.R. [5]
;
Heidel,F.H. [6]
;
Kr?mer,A. [7]
;
Root,D.E. [8]
;
Barbie,D.A. [9]
;
Krivtsov,A.V. [10]
;
Armstrong,S.A. [11]
;
Hahn,W.C. [12]
;
Huntly,B.J. ;
Sykes,S.M. ;
Milsom,M.D. ;
Scholl,C. ;
Fr?hling,S.
作者单位:
Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Division of Stem Cells and
[1]
Department of Translational Oncology, National Center for Tumor Diseases, German Cancer Research
[2]
Immune Cell Development, Host Defense Program, Fox Chase Cancer Center, Philadelphia, PA, United
[3]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
[4]
Department of Haematology, Cambridge Institute of Medical Research, University of Cambridge
[5]
Department of Internal Medicine III, Ulm University, Albert-Einstein-Allee 23, 89081, Ulm, Germany
[6]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States, Broad
[7]
Leukemia Center, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY
[8]
Broad Institute of Harvard, Massachusetts Institute of Technology, Cambridge, MA, United States
[9]
German Consortium for Translational Cancer Research, Heidelberg, Germany, Clinical Cooperation Unit
[10]
German Consortium for Translational Cancer Research, Heidelberg, Germany, Department of Hematology
[11]
Department of Hematology and Oncology, Otto von Guericke University, Magdeburg, Germany
[12]
发布时间
2014-09-25